Literature DB >> 15842585

Evaluation of fatigue in U.S. patients with primary biliary cirrhosis.

Carmen M Stanca1, Nancy Bach, Cynthia Krause, Nidhi Tandon, Maria A Freni, Julio A Gutierrez, Carol Bodian, Jose Lopez, Paul D Berk, Henry C Bodenheimer, Andrea D Branch, Joseph A Odin.   

Abstract

OBJECTIVES: Fatigue, which may have a significant impact on quality of life, is the most common reported symptom in primary biliary cirrhosis (PBC). Multiple instruments to quantify fatigue and quality of life in liver disease have been validated, but have not been broadly applied to U.S. PBC patients. This study examines the extent of fatigue and its effect on quality of life in U.S. PBC patients.
METHODS: Seventy patients with PBC were administered two validated questionnaires about quality of life (the Mayo version of the NIDDK-QA) and fatigue (the Fisk Fatigue Impact Score) and a proposed physical measure of fatigue in PBC (the grip strength test) on the day of routine physician visit. Nonparametric methods were employed.
RESULTS: The fatigue and quality of life domain scores (physical functioning, liver symptoms, health satisfaction, Karnofsky index) discriminated between patients with and without self-reported fatigue (p < 0.05), as opposed to the grip strength results. Fatigue and quality of life domains correlated strongly with each other (r between 0.33 and 0.74, p</= 0.006) and not with the grip strength results. Neither quality of life nor fatigue scores correlated with age.
CONCLUSIONS: The correlation between fatigue and quality of life scores suggests fatigue has an impact on quality of life in U.S. primary biliary cirrhosis patients. However, our fatigue scores suggest U.S. PBC patients have less fatigue than non-U.S. PBC patients. The grip strength is an insensitive measure of fatigue in U.S. PBC patients.

Entities:  

Mesh:

Year:  2005        PMID: 15842585     DOI: 10.1111/j.1572-0241.2005.41315.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

1.  Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort.

Authors:  D E J Jones; N Bhala; J Burt; J Goldblatt; M Prince; J L Newton
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

Review 2.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

3.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

4.  Fatigue severity and factors associated with high fatigue levels in Korean patients with inflammatory bowel disease.

Authors:  Suhyeon Yoo; Yoon Suk Jung; Jung Ho Park; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Dong Il Park
Journal:  Gut Liver       Date:  2013-11-05       Impact factor: 4.519

5.  Muscle fatigue in women with primary biliary cirrhosis: Spectral analysis of surface electromyography.

Authors:  Maria Rosa Biagini; Alessandro Tozzi; Antonello Grippo; Andrea Galli; Stefano Milani; Aldo Amantini
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

6.  Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

Authors:  Jennifer Y Lee; Christopher J Danford; Hirsh D Trivedi; Elliot B Tapper; Vilas R Patwardhan; Alan Bonder
Journal:  Dig Dis Sci       Date:  2019-01-10       Impact factor: 3.199

Review 7.  Recent advances in the development of farnesoid X receptor agonists.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Ann Transl Med       Date:  2015-01

8.  Quality of life and everyday activities in patients with primary biliary cirrhosis.

Authors:  Carlo Selmi; M Eric Gershwin; Keith D Lindor; Howard J Worman; Ellen B Gold; Mitchell Watnik; Jessica Utts; Pietro Invernizzi; Marshall M Kaplan; John M Vierling; Christopher L Bowlus; Marina G Silveira; Ilaria Bossi
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

9.  Deep vein thrombosis and pulmonary embolism in cirrhosis patients.

Authors:  David Gulley; Evgenia Teal; Attaya Suvannasankha; Naga Chalasani; Suthat Liangpunsakul
Journal:  Dig Dis Sci       Date:  2008-04-29       Impact factor: 3.199

10.  Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network.

Authors:  Kristin David; Kris V Kowdley; Aynur Unalp; Fasiha Kanwal; Elizabeth M Brunt; Jeffrey B Schwimmer
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.